The Dr. Hyman Show One Dose That Heals Addiction, PTSD, and Brain Injury? Dr. Nolan Williams on The Science of Ibogaine
59 snips
Sep 3, 2025 
Dr. Nolan Williams, a pioneering Stanford neuropsychiatrist, discusses the groundbreaking potential of ibogaine for treating addiction, PTSD, and depression. He shares how this unique psychedelic can reset the brain and break addiction cycles. The conversation dives into circuit-based psychiatry, highlighting innovative therapies that shift away from traditional methods. With an eye on safety measures, Dr. Williams emphasizes ibogaine's neuroprotective effects and the promise of personalized medicine, stirring excitement for a new era in mental health treatment.
AI Snips
Chapters
Books
Transcript
Episode notes
EEG Slowdown Correlates With Clinical Change
- EEG shows a general slowing of brainwave power after ibogaine that correlates with subjective intensity and PTSD symptom improvement.
- EEG-guided dosing could personalize treatment intensity and therapeutic response.
French Clinical Use Then Scheduling Blocked Research
- Ibogaine saw clinical use in France as a microdose medicine from the 1930s to 1966 before being scheduled.
- It was later placed on Schedule I in the U.S., which hindered scientific study despite low abuse potential.
Use Magnesium To Reduce Cardiac Risk
- Use prophylactic IV magnesium during ibogaine dosing to stabilize the heart and reduce torsades risk.
- Apply established medical protocols and continuous monitoring when using magnesium as mitigation.
